Detalhe da pesquisa
1.
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
BMC Med
; 22(1): 199, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755585
2.
Does the primary treatment sequence affect post-relapse survival in recurrent epithelial ovarian cancer? A real-world multicentre retrospective study.
BJOG
; 129 Suppl 2: 70-78, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485065
3.
The first Chinese National Union of Real-world Gynaecological Oncology Research and Patient Management Platform: A retrospective study.
BJOG
; 129 Suppl 2: 60-69, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485066
4.
PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities.
Drug Discov Today
; 28(8): 103666, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302543
5.
Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study.
J Ovarian Res
; 16(1): 121, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370087
6.
Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery.
J Ovarian Res
; 16(1): 120, 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370173
7.
Sintilimab combined with bevacizumab in relapsed/persistent ovarian clear cell carcinoma (INOVA): an investigator-initiated, multicentre clinical trial-a study protocol of clinical trial.
BMJ Open
; 12(5): e058132, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35613822
8.
Oncological big data platforms for promoting digital competencies and professionalism in Chinese medical students: a cross-sectional study.
BMJ Open
; 12(9): e061015, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109032